| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.27e-07 | 18 | 179 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B ACSL6 ATP6V0B DNAH10 DYNC2H1 RHOBTB3 DDX55 DDX6 ABCB4 DDX10 IFIH1 MDN1 ABCA5 DNAH17 AACS ATP13A3 DNAH8 DNAH9 ABCG5 AFG1L | 6.84e-07 | 614 | 179 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19B DNAH10 DYNC2H1 RHOBTB3 DDX55 DDX6 ABCB4 DDX10 IFIH1 MDN1 ABCA5 ATP13A3 DNAH8 DNAH9 ABCG5 AFG1L | 2.42e-06 | 441 | 179 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.55e-06 | 28 | 179 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.89e-05 | 37 | 179 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 2.41e-05 | 7 | 179 | 3 | GO:0004691 | |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 FAT4 PCDHGB2 PCDHGA3 MATN4 SYT2 ADGRV1 GSN SLIT2 ESYT2 DST LPCAT2 CANT1 SLIT3 C1S PLCB2 FER1L5 UNC13A PADI1 | 4.52e-05 | 749 | 179 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 5.72e-05 | 9 | 179 | 3 | GO:0004690 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX19B DNAH10 DYNC2H1 RHOBTB3 DNM1L DDX55 RGS3 DDX6 ABCB4 DDX10 IFIH1 MDN1 ABCA5 CANT1 SEPTIN14 ATP13A3 DNAH8 DNAH9 ABCG5 AFG1L | 6.70e-05 | 839 | 179 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX19B DNAH10 DYNC2H1 RHOBTB3 DNM1L DDX55 RGS3 DDX6 ABCB4 DDX10 IFIH1 MDN1 ABCA5 CANT1 SEPTIN14 ATP13A3 DNAH8 DNAH9 ABCG5 AFG1L | 6.81e-05 | 840 | 179 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX19B DNAH10 DYNC2H1 RHOBTB3 DNM1L DDX55 RGS3 DDX6 ABCB4 DDX10 IFIH1 MDN1 ABCA5 CANT1 SEPTIN14 ATP13A3 DNAH8 DNAH9 ABCG5 AFG1L | 6.81e-05 | 840 | 179 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19B DNAH10 DYNC2H1 RHOBTB3 DNM1L DDX55 RGS3 DDX6 ABCB4 DDX10 IFIH1 MDN1 ABCA5 SEPTIN14 ATP13A3 DNAH8 DNAH9 ABCG5 AFG1L | 7.12e-05 | 775 | 179 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 8.12e-05 | 10 | 179 | 3 | GO:0004679 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.14e-04 | 70 | 179 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | nucleoside:sodium symporter activity | 4.74e-04 | 4 | 179 | 2 | GO:0005415 | |
| GeneOntologyMolecularFunction | nucleobase:monoatomic cation symporter activity | 4.74e-04 | 4 | 179 | 2 | GO:0015391 | |
| GeneOntologyMolecularFunction | pyrimidine- and adenosine-specific:sodium symporter activity | 4.74e-04 | 4 | 179 | 2 | GO:0015389 | |
| GeneOntologyMolecularFunction | small GTPase binding | DENND5B RAPGEF6 KCTD13 RHOBTB3 DNM1L PPP6R1 AP3M1 PRKACA DENND5A PKN3 | 6.60e-04 | 321 | 179 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | RNA helicase activity | 6.81e-04 | 78 | 179 | 5 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 7.64e-04 | 80 | 179 | 5 | GO:0008186 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 9.66e-04 | 49 | 179 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 1.17e-03 | 6 | 179 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | GTPase binding | DENND5B RAPGEF6 KCTD13 RHOBTB3 DNM1L PPP6R1 AP3M1 PRKACA DENND5A PKN3 | 1.57e-03 | 360 | 179 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 1.63e-03 | 7 | 179 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 2.06e-03 | 60 | 179 | 4 | GO:0005544 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 2.16e-03 | 8 | 179 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | aspartic endopeptidase activity, intramembrane cleaving | 2.16e-03 | 8 | 179 | 2 | GO:0042500 | |
| GeneOntologyBiologicalProcess | regulation of response to cytokine stimulus | 1.04e-05 | 205 | 175 | 10 | GO:0060759 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 5.97e-05 | 25 | 181 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 7.33e-05 | 10 | 181 | 3 | GO:0005952 | |
| GeneOntologyCellularComponent | dynein complex | 1.03e-04 | 54 | 181 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.33e-04 | 12 | 181 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | CATSPERE DNAH10 DYNC2H1 DDX6 DNAH17 PRKACA CATSPERB DNAH8 DNAH9 | 2.38e-04 | 238 | 181 | 9 | GO:0097729 |
| GeneOntologyCellularComponent | cytoplasmic region | DNAH10 DYNC2H1 CFAP36 AP3M1 DST DNAH17 PRKACA DNAH8 DNAH9 HYDIN UNC13A | 3.15e-04 | 360 | 181 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | axoneme | 4.57e-04 | 207 | 181 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | DNAH10 DYNC2H1 CFAP36 AP3M1 DST DNAH17 PRKACA DNAH8 DNAH9 HYDIN | 4.60e-04 | 317 | 181 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | ciliary plasm | 4.72e-04 | 208 | 181 | 8 | GO:0097014 | |
| Domain | ATPase_dyneun-rel_AAA | 1.47e-07 | 14 | 180 | 5 | IPR011704 | |
| Domain | AAA_5 | 1.47e-07 | 14 | 180 | 5 | PF07728 | |
| Domain | DHC_N1 | 5.67e-07 | 8 | 180 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 5.67e-07 | 8 | 180 | 4 | IPR013594 | |
| Domain | C2 | 8.58e-07 | 137 | 180 | 10 | SM00239 | |
| Domain | - | 1.74e-06 | 148 | 180 | 10 | 2.60.40.150 | |
| Domain | C2_dom | 4.39e-06 | 164 | 180 | 10 | IPR000008 | |
| Domain | C2 | 5.06e-06 | 131 | 180 | 9 | PF00168 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.75e-06 | 14 | 180 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.75e-06 | 14 | 180 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.75e-06 | 14 | 180 | 4 | IPR013602 | |
| Domain | DHC_N2 | 7.75e-06 | 14 | 180 | 4 | PF08393 | |
| Domain | MT | 7.75e-06 | 14 | 180 | 4 | PF12777 | |
| Domain | AAA_8 | 7.75e-06 | 14 | 180 | 4 | PF12780 | |
| Domain | C2 | 9.77e-06 | 142 | 180 | 9 | PS50004 | |
| Domain | DHC_fam | 1.05e-05 | 15 | 180 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 1.05e-05 | 15 | 180 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.05e-05 | 15 | 180 | 4 | IPR004273 | |
| Domain | - | DDX19B THNSL1 DNAH10 DYNC2H1 RHOBTB3 DNM1L DDX55 SRPRB DDX6 ABCB4 DDX10 IFIH1 MDN1 ABCA5 SEPTIN14 DNAH8 DNAH9 HYDIN ABCG5 AFG1L | 3.57e-05 | 746 | 180 | 20 | 3.40.50.300 |
| Domain | AAA | 7.86e-05 | 144 | 180 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 7.86e-05 | 144 | 180 | 8 | IPR003593 | |
| Domain | - | 7.93e-05 | 74 | 180 | 6 | 3.40.50.410 | |
| Domain | KCC1 | 9.24e-05 | 2 | 180 | 2 | IPR000622 | |
| Domain | VWFA | 1.41e-04 | 82 | 180 | 6 | PS50234 | |
| Domain | VWA | 1.61e-04 | 84 | 180 | 6 | SM00327 | |
| Domain | P-loop_NTPase | DDX19B THNSL1 DNAH10 DYNC2H1 RHOBTB3 DNM1L DDX55 SRPRB DDX6 ABCB4 DDX10 IFIH1 MDN1 ABCA5 SEPTIN14 DNAH8 DNAH9 HYDIN ABCG5 AFG1L | 2.04e-04 | 848 | 180 | 20 | IPR027417 |
| Domain | C_nuclsd_transpt | 2.75e-04 | 3 | 180 | 2 | IPR008276 | |
| Domain | CNT_C_dom | 2.75e-04 | 3 | 180 | 2 | IPR011657 | |
| Domain | C_nuclsd_transpt_met_bac | 2.75e-04 | 3 | 180 | 2 | IPR018270 | |
| Domain | Gate_dom | 2.75e-04 | 3 | 180 | 2 | IPR011642 | |
| Domain | Nucleos_tra2_N | 2.75e-04 | 3 | 180 | 2 | PF01773 | |
| Domain | Nucleos_tra2_C | 2.75e-04 | 3 | 180 | 2 | PF07662 | |
| Domain | Gate | 2.75e-04 | 3 | 180 | 2 | PF07670 | |
| Domain | CNT_N_dom | 2.75e-04 | 3 | 180 | 2 | IPR002668 | |
| Domain | VWF_A | 3.94e-04 | 99 | 180 | 6 | IPR002035 | |
| Domain | Q_MOTIF | 4.30e-04 | 37 | 180 | 4 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 4.30e-04 | 37 | 180 | 4 | IPR014014 | |
| Domain | FAM47 | 5.47e-04 | 4 | 180 | 2 | PF14642 | |
| Domain | DUF4217 | 5.47e-04 | 4 | 180 | 2 | PF13959 | |
| Domain | FAM47 | 5.47e-04 | 4 | 180 | 2 | IPR032743 | |
| Domain | DUF4217 | 5.47e-04 | 4 | 180 | 2 | SM01178 | |
| Domain | KCL_cotranspt | 5.47e-04 | 4 | 180 | 2 | IPR000076 | |
| Domain | DUF4217 | 5.47e-04 | 4 | 180 | 2 | IPR025313 | |
| Domain | ARM-type_fold | KPNA5 NBEAL1 SCYL3 RICTOR KPNA6 FRYL PPP6R1 ECPAS PDS5A UNC79 | 1.71e-03 | 339 | 180 | 10 | IPR016024 |
| Domain | Arm_3 | 1.88e-03 | 7 | 180 | 2 | PF16186 | |
| Domain | Importing_su_alpha | 1.88e-03 | 7 | 180 | 2 | IPR024931 | |
| Domain | IBB | 1.88e-03 | 7 | 180 | 2 | PF01749 | |
| Domain | SLC12A_fam | 1.88e-03 | 7 | 180 | 2 | IPR004842 | |
| Domain | Arm_3 | 1.88e-03 | 7 | 180 | 2 | IPR032413 | |
| Domain | AGC-kinase_C | 2.07e-03 | 56 | 180 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.07e-03 | 56 | 180 | 4 | PS51285 | |
| Domain | S_TK_X | 2.07e-03 | 56 | 180 | 4 | SM00133 | |
| Pathway | WP_DOPAMINE_METABOLISM | 5.38e-06 | 13 | 135 | 4 | M39622 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 8.47e-06 | 5 | 135 | 3 | M26988 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 2.92e-05 | 7 | 135 | 3 | M47896 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 4.64e-05 | 8 | 135 | 3 | M27840 | |
| Pathway | REACTOME_ROBO_RECEPTORS_BIND_AKAP5 | 6.92e-05 | 9 | 135 | 3 | M27877 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 9.81e-05 | 10 | 135 | 3 | M47648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.19e-04 | 27 | 135 | 4 | M47755 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 1.59e-04 | 29 | 135 | 4 | M39762 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 1.77e-04 | 12 | 135 | 3 | M27950 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 1.77e-04 | 12 | 135 | 3 | M27363 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 1.82e-04 | 30 | 135 | 4 | M42578 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | ACSL6 MTMR12 MOGAT1 GLB1L NR1H3 ACAD10 MED1 ABCB4 PEMT LPCAT2 SYNJ1 ST3GAL5 PRKACA PRKACB PRKACG AACS NFYC CPNE7 | 3.21e-04 | 757 | 135 | 18 | M27451 |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 3.59e-04 | 15 | 135 | 3 | M47794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 3.59e-04 | 15 | 135 | 3 | M47504 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 4.39e-04 | 16 | 135 | 3 | M923 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 4.39e-04 | 16 | 135 | 3 | M47551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 4.39e-04 | 16 | 135 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 4.39e-04 | 16 | 135 | 3 | M47650 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 4.61e-04 | 38 | 135 | 4 | M27856 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 5.29e-04 | 17 | 135 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 5.29e-04 | 17 | 135 | 3 | M47544 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 6.79e-04 | 42 | 135 | 4 | M791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 7.43e-04 | 43 | 135 | 4 | M47669 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 7.44e-04 | 19 | 135 | 3 | M27841 | |
| Pathway | WP_VASOPRESSINREGULATED_WATER_REABSORPTION | 8.11e-04 | 44 | 135 | 4 | M42554 | |
| Pathway | KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION | 8.11e-04 | 44 | 135 | 4 | M9011 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 8.69e-04 | 20 | 135 | 3 | M759 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 8.84e-04 | 45 | 135 | 4 | M47670 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 9.02e-04 | 78 | 135 | 5 | M1921 | |
| Pubmed | MTMR12 RAPGEF6 THNSL1 RHOBTB3 EXOC3 RICTOR PPP6R1 DDX55 RGS3 PHKA2 LLGL2 DST TBK1 AACS GIGYF2 TANC1 DENND5A TOP3A | 1.22e-08 | 650 | 183 | 18 | 38777146 | |
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 2342480 | ||
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 19383776 | ||
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 12842892 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CMBL AGO2 DYNC2H1 SYNE1 RICTOR COG3 ECPAS NDUFA9 GSN DDX6 LLGL2 DST MDN1 PRKACA NQO1 UNC79 DCXR HYDIN | 3.08e-07 | 807 | 183 | 18 | 30575818 |
| Pubmed | DDX19B FAT4 ARID4B DYNC2H1 MED1 NDUFA9 CSMD2 PIAS2 AP3M1 MDN1 UBE3A SERPINB1 IRAK3 ATF3 FER1L5 CAVIN2 | 3.11e-07 | 638 | 183 | 16 | 31182584 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DDX19B SRRM1 THNSL1 ESS2 CFAP36 ACAD9 SYNE1 LRRC49 DNM1L BCKDHA NDUFA9 DDX55 SUCLG2 SRPRB TFCP2 ESYT2 VPS13D FXR1 DST MDN1 NDUFAF7 PRKACA TANC1 DCXR TOP3A | 3.47e-07 | 1496 | 183 | 25 | 32877691 |
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 18385332 | ||
| Pubmed | Mammalian microtubule P-body dynamics are mediated by nesprin-1. | 5.71e-07 | 4 | 183 | 3 | 24862572 | |
| Pubmed | DENND5B SRRM1 DPH2 ATP6V0B AGO2 ARID4B UBE4B ACAD9 DNM1L RICTOR MED1 DDX55 DDX6 FXR1 LLGL2 SLC12A4 UBE3A SLC20A1 GIGYF2 MPHOSPH8 ATP13A3 CAVIN2 CPNE7 | 5.73e-07 | 1327 | 183 | 23 | 32694731 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ERP44 UBE4B DYNC2H1 ACAD9 KPNA6 PPP6R1 NCSTN ECPAS NDUFA9 AP3M1 SRPRB DDX10 SLIT2 ESYT2 LPCAT2 UBE3A TBK1 PDS5A VPS51 | 6.51e-07 | 942 | 183 | 19 | 31073040 |
| Pubmed | ERP44 ACAD9 EXOC3 RICTOR BCKDHA NDUFA9 SUCLG2 FXR1 MDN1 NDUFAF7 TBK1 PNMA2 PDS5A DCXR | 6.80e-07 | 515 | 183 | 14 | 31617661 | |
| Pubmed | 7.13e-07 | 14 | 183 | 4 | 9373155 | ||
| Pubmed | MTMR12 RAPGEF6 RICTOR FRYL PPP6R1 ECPAS SRPRB DDX6 MOB2 DST TBK1 PNMA2 GIGYF2 | 7.95e-07 | 446 | 183 | 13 | 24255178 | |
| Pubmed | HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction. | 1.42e-06 | 5 | 183 | 3 | 21745501 | |
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 12972513 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 19483721 | ||
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 9540970 | ||
| Pubmed | PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity. | 1.42e-06 | 5 | 183 | 3 | 19711044 | |
| Pubmed | SRRM1 AGO2 ARID4B CFAP36 RHOBTB3 BPIFB1 RICTOR BCKDHA KPNA6 PPP6R1 HMG20B SLIT2 FXR1 YEATS4 TBK1 PNMA2 TANC1 PPIH VPS51 ANAPC4 | 2.00e-06 | 1116 | 183 | 20 | 31753913 | |
| Pubmed | 2.14e-06 | 18 | 183 | 4 | 27984743 | ||
| Pubmed | SLC12A6 SRRM1 PCDHGB2 COL20A1 PCDHGA3 SYNE1 FAM47B DDX55 RNF17 TASOR2 ABCB4 CCDC148 FXR1 DST MDN1 SLC12A4 PRKACA PRKACB IRAK3 MPHOSPH8 DNAH8 CAVIN2 ERICH6 | 2.34e-06 | 1442 | 183 | 23 | 35575683 | |
| Pubmed | ZNF131 RAPGEF6 ERP44 LRRC49 PPP6R1 ECPAS PIAS2 HMG20B DST SYNJ1 TBK1 GIGYF2 | 2.50e-06 | 418 | 183 | 12 | 34709266 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 ACAD9 EXOC3 KPNA6 ECPAS AP3M1 SRPRB IFIH1 VPS13D MDN1 GIGYF2 HYDIN ANAPC4 | 2.62e-06 | 497 | 183 | 13 | 36774506 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | KPNA5 ERP44 ACAD9 KPNA6 ECPAS GSN DDX10 FXR1 MDN1 UBE3A TBK1 PRKACA GIGYF2 OS9 ATP13A3 POGLUT2 | 2.73e-06 | 754 | 183 | 16 | 33060197 |
| Pubmed | Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2. | 2.83e-06 | 6 | 183 | 3 | 9837753 | |
| Pubmed | Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. | 2.83e-06 | 6 | 183 | 3 | 19197368 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KPNA5 ZNF131 ESS2 ARID4B KPNA6 PPP6R1 ECPAS TFCP2 HMG20B PHKA2 ESYT2 FXR1 YEATS4 MDN1 NFYC PDS5A ATF3 | 3.25e-06 | 857 | 183 | 17 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DDX19B SRRM1 MTMR12 RAPGEF6 DNM1L RICTOR FRYL DDX6 MOB2 ESYT2 VPS13D FXR1 DST MDN1 SYNJ1 GIGYF2 TANC1 | 3.46e-06 | 861 | 183 | 17 | 36931259 |
| Pubmed | AGO2 HECW1 SYNE1 DNM1L PPP6R1 GSN FXR1 DST MDN1 SYNJ1 UBE3A TBK1 PRKACA PRKACB GIGYF2 LRRC7 UNC79 UNC13A | 3.77e-06 | 963 | 183 | 18 | 28671696 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | KPNA5 SRRM1 MTMR12 ERP44 ACAD9 DNM1L KPNA6 PPP6R1 NCSTN ECPAS SRPRB GSN ESYT2 PTPN7 FXR1 PREP PNMA2 OS9 | 4.40e-06 | 974 | 183 | 18 | 28675297 |
| Pubmed | KPNA5 DDX19B DYNC2H1 RICTOR KPNA6 PPP6R1 SRPRB ESYT2 VPS13D MDN1 TBK1 PDS5A VPS51 PKN3 | 4.50e-06 | 606 | 183 | 14 | 36538041 | |
| Pubmed | 4.94e-06 | 7 | 183 | 3 | 16407073 | ||
| Pubmed | 4.94e-06 | 7 | 183 | 3 | 31178125 | ||
| Pubmed | Phosphorylation of HIV Nef by cAMP-dependent protein kinase. | 4.94e-06 | 7 | 183 | 3 | 15629779 | |
| Pubmed | MTMR12 RAPGEF6 AGO2 RICTOR AP3M1 HMG20B SLC12A4 SYNJ1 UBE3A TANC1 PKN3 | 5.81e-06 | 378 | 183 | 11 | 34315543 | |
| Pubmed | 6.07e-06 | 23 | 183 | 4 | 9730685 | ||
| Pubmed | 6.07e-06 | 23 | 183 | 4 | 9278385 | ||
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 6.15e-06 | 183 | 183 | 8 | 31932471 | |
| Pubmed | CCL3L1 prevents gp120-induced neuron death via the CREB cell signaling pathway. | 7.87e-06 | 8 | 183 | 3 | 19100722 | |
| Pubmed | 7.87e-06 | 8 | 183 | 3 | 12628924 | ||
| Pubmed | 1.18e-05 | 9 | 183 | 3 | 7688126 | ||
| Pubmed | 1.18e-05 | 9 | 183 | 3 | 37903214 | ||
| Pubmed | SRRM1 ZNF131 DPH2 DYNC2H1 ACAD9 SYNE1 EXOC3 RICTOR BCKDHA PPP6R1 NDUFA9 SRPRB TFCP2 DDX10 ESYT2 MDN1 SLC20A1 PRKACA PRKACB OS9 TANC1 DCXR | 1.28e-05 | 1487 | 183 | 22 | 33957083 | |
| Pubmed | DDX19B AGO2 DNM1L KPNA6 NCSTN MED1 ECPAS DDX55 DDX6 ESYT2 FXR1 MDN1 PLXNC1 PREP SERPINB1 GIGYF2 PARP9 ATP13A3 IL2RG | 1.43e-05 | 1168 | 183 | 19 | 19946888 | |
| Pubmed | 1.55e-05 | 150 | 183 | 7 | 32423001 | ||
| Pubmed | HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition. | 1.67e-05 | 10 | 183 | 3 | 20433920 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.93e-05 | 104 | 183 | 6 | 31240132 | |
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 2.09e-05 | 31 | 183 | 4 | 25838543 | |
| Pubmed | SLC12A6 ACSL6 AGO2 KCTD13 SYNE1 LRRC49 DNM1L NDUFA9 NT5DC3 AP3M1 GSN DDX6 FXR1 DST SYNJ1 AKR1B10 PRKACA LRRC7 TANC1 VPS51 UNC13A | 2.31e-05 | 1431 | 183 | 21 | 37142655 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DDX19B THNSL1 ERP44 KCTD13 DYNC2H1 ACAD9 PPP6R1 SUCLG2 AP3M1 SRPRB DDX10 TBK1 PRKACA GIGYF2 PPIH DCXR CPNE7 | 2.54e-05 | 1005 | 183 | 17 | 19615732 |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 16144842 | ||
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 2.75e-05 | 2 | 183 | 2 | 34031912 | |
| Pubmed | Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. | 2.75e-05 | 2 | 183 | 2 | 3023318 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 27154627 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 29307555 | ||
| Pubmed | Choline redistribution during adaptation to choline deprivation. | 2.75e-05 | 2 | 183 | 2 | 17283071 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 36152045 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 38841868 | ||
| Pubmed | MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signaling. | 2.75e-05 | 2 | 183 | 2 | 21156324 | |
| Pubmed | Molecular and behavioral effects of a null mutation in all PKA C beta isoforms. | 2.75e-05 | 2 | 183 | 2 | 12139926 | |
| Pubmed | Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC. | 2.75e-05 | 2 | 183 | 2 | 38351659 | |
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 2.75e-05 | 2 | 183 | 2 | 31835175 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 2833513 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 17553808 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 20591207 | ||
| Pubmed | Post-transcriptional gene silencing activity of human GIGYF2. | 2.75e-05 | 2 | 183 | 2 | 27157137 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 16679290 | ||
| Pubmed | Global consequences of activation loop phosphorylation on protein kinase A. | 2.75e-05 | 2 | 183 | 2 | 19965870 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 15039079 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 12180908 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 22829162 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 15003449 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 31678302 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 10455109 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 17510708 | ||
| Pubmed | Systems-level identification of PKA-dependent signaling in epithelial cells. | 2.75e-05 | 2 | 183 | 2 | 28973931 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 23536558 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 37871652 | ||
| Pubmed | The role of phosphatidylethanolamine methyltransferase in a mouse model of intrahepatic cholestasis. | 2.75e-05 | 2 | 183 | 2 | 21292027 | |
| Pubmed | Transcription factors involved in the expression of SLC28 genes in human liver parenchymal cells. | 2.75e-05 | 2 | 183 | 2 | 17187757 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 33171123 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SRRM1 AGO2 ERP44 ADCK1 ACAD10 SRPRB DDX6 PHKA2 YEATS4 DST TBK1 PRKACB IRAK3 POGLUT2 VPS51 ANAPC4 | 2.80e-05 | 910 | 183 | 16 | 36736316 |
| Pubmed | 3.04e-05 | 12 | 183 | 3 | 10830164 | ||
| Pubmed | 3.04e-05 | 12 | 183 | 3 | 22981605 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 3.12e-05 | 298 | 183 | 9 | 32353859 | |
| Pubmed | SRRM1 ACAD9 BPIFB1 KPNA6 ECPAS FANCC FXR1 DST MDN1 PDS5A OS9 CAVIN2 ANAPC4 | 3.45e-05 | 634 | 183 | 13 | 34591612 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | KPNA5 MTMR12 ERP44 ACAD9 BPIFB1 BCKDHA KPNA6 XRCC4 NDUFA9 SRPRB PHKA2 PTPN7 YEATS4 CANT1 PNMA2 OS9 | 3.67e-05 | 931 | 183 | 16 | 27432908 |
| Pubmed | Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. | 3.94e-05 | 13 | 183 | 3 | 18836454 | |
| Pubmed | 3.94e-05 | 13 | 183 | 3 | 19895210 | ||
| Pubmed | The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells. | 3.94e-05 | 13 | 183 | 3 | 20402410 | |
| Pubmed | 3.94e-05 | 13 | 183 | 3 | 20392842 | ||
| Pubmed | 3.94e-05 | 13 | 183 | 3 | 19700621 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CMBL DDX19B SRRM1 ERP44 BCKDHA KPNA6 FRYL XRCC4 ECPAS NDUFA9 SRPRB GSN DDX6 FANCC PRKACA PNMA2 PDS5A LRRC7 UNC79 | 5.17e-05 | 1284 | 183 | 19 | 17353931 |
| Pubmed | 6.22e-05 | 15 | 183 | 3 | 23821580 | ||
| Pubmed | 6.22e-05 | 15 | 183 | 3 | 18345009 | ||
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 6.22e-05 | 15 | 183 | 3 | 2165385 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ERP44 DNAH10 DYNC2H1 ACAD9 SYNE1 DNM1L KPNA6 ECPAS DDX55 SRPRB TFCP2 DDX6 DDX10 FXR1 MDN1 TBK1 PRKACA GIGYF2 PDS5A MPHOSPH8 | 6.75e-05 | 1425 | 183 | 20 | 30948266 |
| Pubmed | 7.63e-05 | 16 | 183 | 3 | 17715346 | ||
| Pubmed | DENND5B ESS2 ERP44 NBEAL1 DNM1L ACAD10 NCSTN PIAS2 TFCP2 ESYT2 MDN1 SYNJ1 INTS15 | 8.01e-05 | 689 | 183 | 13 | 36543142 | |
| Interaction | NPTN interactions | DDX19B ZWILCH KCTD13 NBEAL1 DYNC2H1 ACAD10 SYT2 COG3 ECPAS SRPRB SPPL2A MDN1 PDS5A VPS51 | 2.32e-07 | 278 | 181 | 14 | int:NPTN |
| Interaction | GPR182 interactions | DDX19B ZWILCH RHOBTB3 ADCK1 EXOC3 ACAD10 PPP6R1 COG3 ECPAS NDUFA9 ESYT2 MDN1 LPCAT2 CANT1 PDS5A ATP13A3 VPS51 | 7.97e-07 | 455 | 181 | 17 | int:GPR182 |
| Interaction | PHF21A interactions | RAPGEF6 LRRC49 PPP6R1 ECPAS HMG20B LLGL2 YEATS4 DST SYNJ1 TBK1 GIGYF2 VPS51 PKN3 | 1.42e-05 | 343 | 181 | 13 | int:PHF21A |
| GeneFamily | Dyneins, axonemal | 5.15e-06 | 17 | 127 | 4 | 536 | |
| GeneFamily | DEAD-box helicases | 2.11e-04 | 42 | 127 | 4 | 499 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ACSL6 RAPGEF6 LRRC49 RICTOR GRIK1 LRRC2 CSMD2 CPNE5 PIAS2 NT5DC3 MDN1 SYNJ1 KCNC2 ST3GAL5 PLXNC1 PRKACB PNMA2 LRRC7 UNC79 HYDIN UNC13A PDZRN4 | 1.02e-05 | 1106 | 183 | 22 | M39071 |
| Coexpression | GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN | 1.21e-05 | 200 | 183 | 9 | M5724 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | RAPGEF6 ARID4B CFAP36 EXOC3 DNM1L XRCC4 TASOR2 DDX10 IFIH1 FXR1 YEATS4 ABCA5 UBE3A PLXNC1 TBK1 MPHOSPH8 | 1.60e-05 | 656 | 183 | 16 | M18979 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | FAT4 PECAM1 RGS3 GSN SERPINE2 DST LPCAT2 AKR1B10 NQO1 ATP13A3 | 1.12e-08 | 200 | 183 | 10 | ac9ead34afa14067171833f5c277eaf06db7b02e |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL6A3 RHOBTB3 HTRA3 GRIK1 GSN SLIT2 SERPINE2 SLIT3 C1S PDZRN4 | 1.12e-08 | 200 | 183 | 10 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL6A3 RHOBTB3 HTRA3 GRIK1 GSN SLIT2 SERPINE2 SLIT3 C1S PDZRN4 | 1.12e-08 | 200 | 183 | 10 | 3a164e3971bcd62b148b813171c103adb81f972e |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-08 | 162 | 183 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-08 | 166 | 183 | 9 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-07 | 199 | 183 | 9 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.51e-07 | 200 | 183 | 9 | 20112be28f80baffad92641c9cfd7c3718967dbb | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-07 | 160 | 183 | 8 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-07 | 160 | 183 | 8 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.28e-07 | 177 | 183 | 8 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.28e-07 | 177 | 183 | 8 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-07 | 179 | 183 | 8 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.06e-06 | 186 | 183 | 8 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.34e-06 | 192 | 183 | 8 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.45e-06 | 194 | 183 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-06 | 194 | 183 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.45e-06 | 194 | 183 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-06 | 195 | 183 | 8 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-06 | 196 | 183 | 8 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-06 | 196 | 183 | 8 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-06 | 196 | 183 | 8 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.63e-06 | 197 | 183 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-06 | 198 | 183 | 8 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-06 | 199 | 183 | 8 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-06 | 199 | 183 | 8 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-06 | 199 | 183 | 8 | 993fa050a095017135a6e723c77cd38b9d782e58 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-06 | 199 | 183 | 8 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-06 | 199 | 183 | 8 | f835e7ffe976843b0edbf695762d463da85793f3 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-06 | 199 | 183 | 8 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-06 | 200 | 183 | 8 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-06 | 200 | 183 | 8 | 665df8391d2ebcfc6536318612f4992852b5e2b8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 1.82e-06 | 200 | 183 | 8 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-06 | 200 | 183 | 8 | 5c6520dc4c4693827f6680651785680b5883afb8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-06 | 160 | 183 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-06 | 160 | 183 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-06 | 167 | 183 | 7 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-06 | 173 | 183 | 7 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-06 | 173 | 183 | 7 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | wk_15-18-Epithelial-PNS-COL20A1+_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.79e-06 | 177 | 183 | 7 | b8cc6a7abf83a9844a5293b6cc4b19135b51fd53 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 178 | 183 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 181 | 183 | 7 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 181 | 183 | 7 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 183 | 183 | 7 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 183 | 183 | 7 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 183 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 183 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 183 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 186 | 183 | 7 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 187 | 183 | 7 | 7beba2a5d5978f2ae7d8bde10815705cf2572211 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 188 | 183 | 7 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 188 | 183 | 7 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.31e-05 | 125 | 183 | 6 | 6cd741dd1c7ee6b16437cca7c15c99b5c95603fc | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 189 | 183 | 7 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 189 | 183 | 7 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 189 | 183 | 7 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-05 | 189 | 183 | 7 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 190 | 183 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 190 | 183 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.39e-05 | 190 | 183 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-05 | 191 | 183 | 7 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-05 | 191 | 183 | 7 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.49e-05 | 192 | 183 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 192 | 183 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 192 | 183 | 7 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.54e-05 | 193 | 183 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-05 | 193 | 183 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.54e-05 | 193 | 183 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.54e-05 | 193 | 183 | 7 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 194 | 183 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.65e-05 | 195 | 183 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.65e-05 | 195 | 183 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.65e-05 | 195 | 183 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.65e-05 | 195 | 183 | 7 | 72f42f0be53a2a61f61647118b4883e752d998a5 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.65e-05 | 195 | 183 | 7 | 49a4f58aac168fc1838bd5d2b202135cd794c28b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 196 | 183 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.70e-05 | 196 | 183 | 7 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.76e-05 | 197 | 183 | 7 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 1.76e-05 | 197 | 183 | 7 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 197 | 183 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-05 | 197 | 183 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Severe-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.82e-05 | 198 | 183 | 7 | 8402421dc060926e968efe39a4e907f1e8ae5b1f | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-05 | 198 | 183 | 7 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-05 | 198 | 183 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-05 | 198 | 183 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-05 | 199 | 183 | 7 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-05 | 199 | 183 | 7 | b03539908131308d7bf5036e78c4c840a6a79a17 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.88e-05 | 199 | 183 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.88e-05 | 199 | 183 | 7 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.88e-05 | 199 | 183 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.88e-05 | 199 | 183 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 368C-Fibroblasts|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-05 | 199 | 183 | 7 | dbf64b83e2dc311b68f299c3f306ee098efd664c | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.88e-05 | 199 | 183 | 7 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.88e-05 | 199 | 183 | 7 | 7d071c88a003babf6dbdb84dde561fc03c92f375 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 183 | 7 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 183 | 7 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 183 | 7 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK|COVID-19_Mild / Disease, condition lineage and cell class | 1.94e-05 | 200 | 183 | 7 | 885fcb6c6c744f89fc983a617303e6f57126d908 | |
| Drug | NSC56408 | 3.34e-08 | 62 | 182 | 8 | CID000005604 | |
| Drug | gemfibrozil | DDX19B AGO2 PECAM1 NR1H3 NCSTN MED1 ABCB4 UGT1A1 SLC12A4 AKR1B10 ABCG5 | 1.84e-06 | 222 | 182 | 11 | CID000003463 |
| Drug | AC1L1B9H | 3.04e-06 | 78 | 182 | 7 | CID000001341 | |
| Disease | mean platelet volume | SLC12A6 SRRM1 PCDHGB2 PCDHGA3 PECAM1 DNM1L FRYL CPNE5 RGS3 KLHL29 ESYT2 SERPINE2 ST3GAL5 NQO1 CATSPERB ATP13A3 CAVIN2 | 1.58e-04 | 1020 | 178 | 17 | EFO_0004584 |
| Disease | alpha 1-antitrypsin deficiency (implicated_via_orthology) | 7.45e-04 | 7 | 178 | 2 | DOID:13372 (implicated_via_orthology) | |
| Disease | susceptibility to mononucleosis measurement | 8.15e-04 | 69 | 178 | 4 | EFO_0008403 | |
| Disease | Ischemic stroke | 8.24e-04 | 324 | 178 | 8 | HP_0002140 | |
| Disease | Malignant neoplasm of breast | KPNA5 ATP6V0B CATSPERE DYNC2H1 SYNE1 COG3 GSN DDX10 SERPINE2 FXR1 LLGL2 NQO1 NFYC SLC28A1 LRRC7 DNAH9 | 8.35e-04 | 1074 | 178 | 16 | C0006142 |
| Disease | Non-alcoholic Fatty Liver Disease | 8.61e-04 | 70 | 178 | 4 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 8.61e-04 | 70 | 178 | 4 | C3241937 | |
| Disease | coronary artery disease | COL6A3 FAT4 DNAH10 NBEAL1 DYNC2H1 PECAM1 LRRC2 ACAD10 IFIH1 PEMT GIGYF2 C1S PLCB2 LRRC7 ATF3 DENND5A UNC13A | 9.46e-04 | 1194 | 178 | 17 | EFO_0001645 |
| Disease | urinary bladder cancer (implicated_via_orthology) | 1.27e-03 | 9 | 178 | 2 | DOID:11054 (implicated_via_orthology) | |
| Disease | interleukin 10 measurement | 1.29e-03 | 78 | 178 | 4 | EFO_0004750 | |
| Disease | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, obsolete_red blood cell distribution width, basophil count, platelet count, eosinophil count | 1.92e-03 | 11 | 178 | 2 | EFO_0004305, EFO_0004308, EFO_0004309, EFO_0004526, EFO_0004528, EFO_0004584, EFO_0004833, EFO_0004842, EFO_0005090, EFO_0005091, EFO_0005192 | |
| Disease | leukemia (is_implicated_in) | 2.70e-03 | 13 | 178 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | hypertension | 2.71e-03 | 307 | 178 | 7 | EFO_0000537 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 3.14e-03 | 14 | 178 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | epilepsy (implicated_via_orthology) | 3.16e-03 | 163 | 178 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 3.24e-03 | 49 | 178 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | blood phosphate measurement | 4.17e-03 | 174 | 178 | 5 | EFO_0010972 | |
| Disease | muscular dystrophy (is_implicated_in) | 4.64e-03 | 17 | 178 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.64e-03 | 17 | 178 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Cannabis use initiation | 5.20e-03 | 18 | 178 | 2 | EFO_0007586 | |
| Disease | Myeloid Leukemia | 5.20e-03 | 18 | 178 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 5.20e-03 | 18 | 178 | 2 | C0023466 | |
| Disease | fibroblast growth factor basic measurement | 5.48e-03 | 59 | 178 | 3 | EFO_0008130 | |
| Disease | myocardial infarction | 5.52e-03 | 350 | 178 | 7 | EFO_0000612 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 5.78e-03 | 19 | 178 | 2 | DOID:10003 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNKPEIFELIQEIFA | 636 | Q9UPW8 | |
| TPFFQEITDIVFKIE | 1006 | Q8WWZ7 | |
| KVEFPEARIFEETLN | 251 | Q8WZ19 | |
| PDAVLKQAFEQALEF | 241 | Q4LE39 | |
| IPEKQIIDDIVFDFQ | 386 | Q7L0X2 | |
| QFIEKLFRETIEPAV | 211 | A0FGR8 | |
| QAVNVVINFDFPKLA | 401 | P26196 | |
| EVLVLAVKQLFPEFE | 201 | Q86TW2 | |
| IPNAIQIVTESEKFF | 141 | Q8IYS0 | |
| EALRKQVAVVAQFDP | 491 | Q8NFR7 | |
| FRVVGEKQLPQEIIF | 11 | Q9UJX5 | |
| QIVKILTQDTPEFFI | 336 | Q8TDL5 | |
| IKIFPTVLTFLVDQE | 351 | Q9H7T0 | |
| LDFTEKFQPVVQLFD | 756 | Q5SY80 | |
| NDIDVEPQFDFLVIK | 621 | Q7Z408 | |
| LFVPEVSFELLVKRQ | 406 | O00429 | |
| FSQIQPKLIFSVEAV | 196 | Q86V21 | |
| TVPVDFQNVLEDFTK | 666 | Q9H7F0 | |
| SIPILDFVEQKCEVF | 26 | Q96G28 | |
| ILQPVLAAEDFTIFK | 96 | Q96G28 | |
| VENEPVNVEELAFKF | 46 | P39086 | |
| LFELTVKANDQAVPI | 1491 | Q6V0I7 | |
| EINQFLGPVEKFFTE | 66 | Q9H845 | |
| GFQITKLIVEEPEFN | 2236 | Q8WXG9 | |
| LQRANFVPFIAVLKE | 256 | Q8WV93 | |
| RLAAKVNEEEEFIPQ | 201 | Q6ZMN8 | |
| KLANFPEVDVFVLLA | 326 | Q9BQC3 | |
| SFLPLDRKQFDVIVE | 166 | Q6JQN1 | |
| TPARIVENIQVFDFK | 266 | O60218 | |
| RDKLFFVSVIQTEVP | 61 | Q9Y2T2 | |
| KAQPVIEFVCEVLDF | 226 | Q9UKV8 | |
| NIFPVLIEILQKAEF | 381 | O15131 | |
| QFLDVDFEKLPTRVD | 36 | Q6ZS30 | |
| VEAFRNAKEPIVVQV | 296 | Q6ZMN7 | |
| LFADVVPKTAENFRQ | 31 | O43447 | |
| AESDIVDIPQLFFLK | 561 | Q9ULC6 | |
| IFTNKEVQLAQIFEP | 746 | Q29RF7 | |
| FFPVQEEDDQKRLLV | 206 | P49796 | |
| QLEEEFLKIPSNFVS | 96 | P35236 | |
| QLTVKFVIFPTDLEI | 461 | Q8IXQ6 | |
| ELLEEFVFQVPKERS | 46 | Q96N11 | |
| KFPVQLENVDSFVEL | 351 | Q92542 | |
| LQVEFINPIFEFSRA | 331 | Q13133 | |
| TDFQFKELVVLPREI | 36 | Q70IA6 | |
| QPARKAFVEEVEAQL | 111 | Q5HY64 | |
| LVPVVSFGENELFKQ | 221 | Q96PD6 | |
| DANIFPVLIEILQKA | 376 | O60684 | |
| NEKRILQAVNFPFLV | 91 | P17612 | |
| SIFNFKEVEVQLLPE | 781 | Q14667 | |
| EFLVRIVFSPNKLEF | 296 | Q96PR1 | |
| DTIFQPFLKDVNELR | 5271 | Q9NU22 | |
| KRFVNQIVDFLDVSP | 406 | O95460 | |
| LLVVSEEQFKVFTLP | 811 | Q6P1M3 | |
| LRQNDKEEVPVFLLF | 441 | Q9C0I1 | |
| QVPKEVFNFERTLEE | 36 | Q96NW7 | |
| VSKSPVQFENLEEIF | 2916 | Q03001 | |
| FVEDFIQVPRNLVGK | 281 | P51114 | |
| NDKIVAFLRQPNIFE | 1116 | Q76N89 | |
| IPQFTLNFVEFNLEK | 181 | Q9H252 | |
| FEASINTILEFLPKQ | 181 | Q8NHQ9 | |
| SFKFIPNTDDQIIVA | 346 | Q8WVQ1 | |
| TKEDRFQEFSNIVIP | 1646 | Q5VYK3 | |
| DVVQFLPEDIIIQTF | 76 | Q12988 | |
| FSTVALNVVFEKIPE | 1196 | O60486 | |
| AKTEFNFLNITPELV | 761 | Q9Y5G2 | |
| KNSRDQNFVILEFPV | 181 | P16284 | |
| VALLQPFLEVTKEAF | 86 | Q7Z4W1 | |
| EIKINAAQEEFRPAA | 3671 | Q96JB1 | |
| DTPLNIFVKIIQFIA | 401 | O94915 | |
| QPARKAFVEEVEAQL | 111 | Q8NA70 | |
| FTFIEFDEIVQVLPK | 446 | Q8IUZ0 | |
| LPFELSNLKQVTFVD | 206 | Q9BYS8 | |
| EIEVPFVTRNKDVFQ | 121 | P07093 | |
| FPNILFKETANVTVD | 121 | Q9Y616 | |
| VIFKTPNQDTEFLER | 91 | Q9UL42 | |
| FEDVFVKIPQAIAQL | 141 | Q16795 | |
| VDINDIFQVKDIPYF | 1431 | Q6R327 | |
| TKFDQFDFLIDIVPR | 106 | Q13952 | |
| FVPAEKIVINFITLN | 301 | Q9UHF4 | |
| KLEAADLVIFQFPLQ | 91 | P15559 | |
| VAAFFNVSKIPERIQ | 286 | Q6ZVX9 | |
| VIFDIIDNNPKIDSF | 366 | P21439 | |
| KFLDFEVRNEVQLIV | 2201 | Q6V1P9 | |
| KEARVTVFPFNILDN | 126 | Q9UBM1 | |
| FIIPDQETKNEFRNL | 501 | Q5T6X5 | |
| PSNTEEIIQVAFKLF | 426 | Q7L5N7 | |
| NQLVFAEPVAVKSFL | 296 | Q8IZE3 | |
| QVEVFVLGNLPFKLE | 381 | Q9Y5H0 | |
| AFVEAQNKITVPFLE | 41 | P48147 | |
| LVFFKLRPEVITDEN | 76 | Q8NCM8 | |
| IQRDFFPDVEKLQAQ | 51 | Q96DF8 | |
| NFIADVVEKIAPAVV | 141 | P83110 | |
| SKLFFNNVFTVEPLE | 396 | Q4G0P3 | |
| NEKRILQAVNFPFLV | 91 | P22694 | |
| NEKRILQAIDFPFLV | 91 | P22612 | |
| NLDVPTFVSFLKEVE | 1151 | Q6Y7W6 | |
| TEFFEKPDVQVLVLT | 41 | Q9UFH2 | |
| QQVKDFLASVIAPFE | 196 | Q9P218 | |
| DTEFILFKPVRNNIQ | 776 | Q96JB2 | |
| DIVQFVPFRELKNAS | 576 | Q9UBL6 | |
| VAVIQFSDDPKVEFL | 1271 | P12111 | |
| QVSVVINFDLPVDKD | 401 | Q9UMR2 | |
| QPEFFEAVNEAILLK | 216 | Q00597 | |
| FALRDVISKFQEVPL | 346 | Q6UWU2 | |
| VLLVEQLFRKEFQPF | 366 | Q9BYX4 | |
| VEEFQVPYNKLQVIF | 96 | P09871 | |
| FPNKVDFIQELSEVL | 386 | Q6ZUT9 | |
| QPRSELFQLFDKIAI | 251 | Q9H222 | |
| NLTPFVKEELRFAIQ | 36 | P18847 | |
| FPNKLEFVQEVSEIL | 401 | Q6IQ26 | |
| KEEFPNENQVVFARV | 76 | Q9BS26 | |
| SKENPFLFALEAVVI | 251 | P31785 | |
| PFSFQNVLVVLEDKE | 251 | Q5T7N3 | |
| FKHVVPNEVVVQRLF | 176 | P06396 | |
| FIEVNVSLPRFKLEE | 266 | P30740 | |
| EKINVNEITRFSDFP | 61 | Q13206 | |
| LFSEVVLPVLANEKN | 136 | Q9NYC9 | |
| IALEVKQPSIFQELE | 3936 | Q8NDH2 | |
| AAVENLKNIFSVPEI | 111 | O60645 | |
| QEELKNFGVIVLAFP | 86 | P59796 | |
| KVLIFQEENEIPASV | 156 | O95810 | |
| LVANLQPVFTELFKF | 316 | Q8IVF4 | |
| QAIAKDNIIPFLRVF | 596 | Q9UHW9 | |
| QDKPEVSLLFQFLQI | 506 | Q8WUM9 | |
| FQVFVFESLLPDKVE | 121 | Q9BZW8 | |
| EVIDNTLNPDFVRKF | 66 | Q9HCH3 | |
| PELVQQLREKNFDEF | 136 | Q15648 | |
| RVALEVTEDNKFFPI | 301 | Q96LW4 | |
| PAFAVEDVNLVNVTK | 266 | P46019 | |
| AVVLNDKFQLPVFLD | 806 | Q99549 | |
| FIDKLEFIQPNVISG | 61 | P12694 | |
| KSVPQEFILLVFSDQ | 6 | Q9GZK3 | |
| EKFFIFALTPQQVRE | 176 | O75928 | |
| EQDAEEIKVQPFFRT | 806 | Q6P5Z2 | |
| LIFSQKPEFQDLSVE | 561 | O94955 | |
| PIFTEEFLDQNKARE | 186 | Q9P0W2 | |
| FSFEIPFEQIQKVQV | 341 | Q8N9I0 | |
| RVNVPEFQKDAILAA | 936 | A5PLK6 | |
| EFEFSQLPLKVEFLE | 231 | Q9Y5M8 | |
| SDIPDQVIRVFKVDQ | 746 | Q8TEU7 | |
| QPVSFQEIFEAKRQE | 326 | Q6ZU15 | |
| PLQQARTLFDEVQFK | 7596 | Q8NF91 | |
| LAEKPQLVTRFQEVF | 411 | O43426 | |
| SPQDIKFQDLVVFIL | 26 | P04053 | |
| PAKFFDETILIQVVN | 221 | A0AVI2 | |
| PDVVLQELFFKLTSQ | 791 | Q969F9 | |
| VFVDIDPQVSDKLRF | 236 | Q7L592 | |
| LFDVVIVQAEKPNFF | 321 | Q86UY8 | |
| FRILNPVIIKETAFD | 306 | Q9UNP4 | |
| ANFQEIISALPFVKL | 631 | Q9C0D5 | |
| DLVPLVKNQVFEFLI | 746 | Q8N3P4 | |
| IFFNILVPGAEEAQK | 621 | Q13438 | |
| NPFIFTLRNDKVIEA | 286 | Q8NGU2 | |
| QAIAKDNIIPFLRVF | 531 | Q9UP95 | |
| TLVKDVFAFQALPII | 251 | O43868 | |
| KVIFPRQDDVLISFL | 306 | Q9UKU0 | |
| TLFIFAENDVVIPLK | 171 | Q96DG6 | |
| VIEVVEKQFDQLLAF | 186 | Q9BXT8 | |
| VAIKEFNPLSILVQF | 1501 | Q9BXT8 | |
| LKEIPIQDVAIQDFT | 696 | O75094 | |
| IDVFSPVEFNKVSVL | 686 | Q9UID3 | |
| LFLKIDATQVEVNPF | 231 | Q96I99 | |
| NENDIVFIVEKVPLE | 56 | Q9H900 | |
| SKEFFQLVVEEIFNP | 571 | Q05086 | |
| GVPFRVQIDTFKENE | 206 | Q12800 | |
| VVIEFIFNQLEVKNP | 66 | Q8IYB3 | |
| QDEEVFKQIFIPILQ | 511 | O95155 | |
| DAQNPSLFVKILIVE | 166 | Q99437 | |
| NRSEFPDVKILIAFI | 126 | Q8TCT8 | |
| FNLEKVENPAEVIRE | 111 | Q13426 | |
| VPFQREDVKESFVSL | 81 | P22309 | |
| KRNFTNFPFLEEIIV | 421 | Q8IZ13 | |
| NDKQRIAVVAFFPEN | 396 | Q8IYQ7 | |
| FLKEIPIQDVAIQDF | 696 | O94813 | |
| KQFNPFSVDRIDVVV | 666 | Q00722 | |
| FQVKVSAPEEQFTRV | 71 | Q6UW63 | |
| ALVKDVFAFQVLPII | 256 | O00337 | |
| FVVERFKAIQAFVPE | 251 | Q13472 | |
| DRLKEFNFPEEAVLQ | 536 | Q9UPN7 | |
| VVDFITPANFEKVLS | 71 | O15060 | |
| VNNFIENIEKIAAPF | 2411 | Q5VWN6 | |
| KFFQEFTQEPLVEIE | 61 | P52739 | |
| FEIIIKIFFIDPNER | 96 | O95619 | |
| AIKVFNNISFLRPVD | 36 | Q9UHD2 | |
| DFQFDTVVKDRPTIL | 1131 | Q9P2D8 | |
| NDVQLFLAIAKSIPE | 2581 | Q5THJ4 | |
| KAFALQIFPEVAAQE | 456 | Q96CT2 |